Published in Cancer Weekly, April 22nd, 2003
According to published research from Japan, "tumor angiogenesis is initiated by angiogenic factors that are produced in large amounts by hypoxic tumor cells. The inhibition of this step may lead to tumor-specific antiangiogenesis because normal tissues are not usually hypoxic. On the other hand, blocking a biological function of endothelial cells is known to result in angiogenic inhibition."
"To produce a tumor-specific and powerful antiangiogenesis, we determined whether potent angiogenic inhibition could be achieved by inhibiting the production of angiogenic factors by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.